GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $129.18 $142.00 Friday, 19th Apr 2024 DXCM stock ended at $130.71. This is 2.67% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.55% from a day low at $129.18 to a day high of $135.06.
90 days $113.05 $142.00
52 weeks $74.75 $142.00

Historical DexCom prices

Date Open High Low Close Volume
2024-02-07 $124.92 $127.09 $124.28 $126.61 2 237 764
2024-02-06 $121.81 $124.98 $120.47 $124.92 1 985 149
2024-02-05 $120.71 $121.80 $119.60 $121.23 2 713 015
2024-02-02 $122.21 $122.45 $119.63 $120.96 2 483 794
2024-02-01 $122.15 $123.84 $119.93 $122.60 2 067 815
2024-01-31 $121.23 $123.05 $120.12 $121.35 2 278 883
2024-01-30 $123.14 $123.24 $120.61 $120.79 2 578 357
2024-01-29 $121.88 $124.26 $119.55 $124.25 2 179 167
2024-01-26 $126.07 $126.39 $119.71 $121.96 3 729 665
2024-01-25 $129.14 $129.39 $125.24 $126.51 1 641 655
2024-01-24 $128.10 $128.56 $125.74 $127.42 1 644 242
2024-01-23 $129.15 $129.32 $125.39 $127.12 1 753 620
2024-01-22 $129.20 $130.31 $128.65 $129.29 3 133 329
2024-01-19 $127.12 $127.99 $125.06 $127.29 2 697 570
2024-01-18 $126.26 $128.00 $125.30 $127.45 2 753 059
2024-01-17 $123.00 $125.53 $122.54 $125.45 1 806 138
2024-01-16 $123.59 $124.87 $121.29 $124.46 2 939 226
2024-01-12 $128.93 $129.99 $124.06 $125.00 3 478 537
2024-01-11 $127.97 $130.30 $126.72 $128.93 2 431 736
2024-01-10 $130.04 $130.74 $127.97 $128.00 2 340 666
2024-01-09 $128.81 $132.03 $128.38 $129.70 2 630 951
2024-01-08 $125.71 $130.32 $123.88 $129.63 3 602 044
2024-01-05 $121.27 $124.99 $120.51 $123.98 1 919 277
2024-01-04 $120.03 $122.80 $119.86 $121.83 1 945 633
2024-01-03 $123.44 $123.44 $119.65 $120.27 1 707 348
Click to get the best stock tips daily for free!

About DexCom

DexCom DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to i... DXCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT